|
Volumn 6, Issue 6, 2006, Pages 533-536
|
Depression in physical illness
|
Author keywords
Antidepressant; Depression; Mood disorders; Physical illness; Suicide
|
Indexed keywords
AMANTADINE;
AMITRIPTYLINE;
ANABOLIC AGENT;
ANTIARRHYTHMIC AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIHYPERTENSIVE AGENT;
ANTIPARKINSON AGENT;
ANTIRETROVIRUS AGENT;
CIMETIDINE;
CLONIDINE;
CORTICOSTEROID DERIVATIVE;
CYTOTOXIC AGENT;
DIGOXIN;
FLUOXETINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
INTERFERON;
LEVODOPA;
MONOAMINE OXIDASE INHIBITOR;
NIFEDIPINE;
ORAL CONTRACEPTIVE AGENT;
PROCAINAMIDE;
PROPRANOLOL;
RESERPINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
VENLAFAXINE;
VINCRISTINE;
BEHAVIOR THERAPY;
CLINICAL FEATURE;
CLINICAL TRIAL;
COGNITIVE THERAPY;
CONTROLLED CLINICAL TRIAL;
DEPRESSION;
DIAGNOSTIC TEST;
DISEASE ASSOCIATION;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
HEALTH CARE COST;
HUMAN;
MEDICAL SPECIALIST;
MOOD;
PATHOGENESIS;
PATIENT REFERRAL;
PHYSICAL DISABILITY;
PHYSICAL DISEASE;
PREVALENCE;
PROBLEM SOLVING;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SYSTEMATIC REVIEW;
UNSPECIFIED SIDE EFFECT;
|
EID: 33845979525
PISSN: 14702118
EISSN: None
Source Type: Journal
DOI: 10.7861/clinmedicine.6-6-533 Document Type: Review |
Times cited : (4)
|
References (8)
|